Acurx Pharmaceuticals (ACXP) Income Statement (2020 - 2026)
Income Statement report data from Mar 31, 2020 to Mar 31, 2026 for Acurx Pharmaceuticals (ACXP).
All data is split-adjusted. You can find the most accurate data from the reports on the SEC official website. We recommend verify information using official company filings before making investment decisions.
Reported currency: USD
| Mar 31, 2026 | Dec 31, 2025 | Sep 30, 2025 | Jun 30, 2025 | Mar 31, 2025 | Dec 31, 2024 | Sep 30, 2024 | Jun 30, 2024 | Mar 31, 2024 | Dec 31, 2023 | Sep 30, 2023 | Jun 30, 2023 | Mar 31, 2023 | Dec 31, 2022 | Sep 30, 2022 | Jun 30, 2022 | Mar 31, 2022 | Dec 31, 2021 | Sep 30, 2021 | Jun 30, 2021 | Mar 31, 2021 | Dec 31, 2020 | Sep 30, 2020 | Jun 30, 2020 | Mar 31, 2020 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Operating Expenses | |||||||||||||||||||||||||
Research And Development | 340K (+21.43%) | 280K (-34.88%) | 430K (-17.31%) | 520K (-13.33%) | 600K (-27.71%) | 830K (-30.83%) | 1.20M (-34.43%) | 1.83M (+17.31%) | 1.56M (-19.59%) | 1.94M (+43.70%) | 1.35M (-22.41%) | 1.74M (+70.59%) | 1.02M (-28.67%) | 1.43M (-10.06%) | 1.59M (+74.73%) | 910K (+10.98%) | 820K (+13.89%) | 720K (-36.28%) | 1.13M (+1030.00%) | 100K (+11.11%) | 90K (-92.11%) | 1.14M (+72.73%) | 660K (+65.00%) | 400K | - |
Selling General And Administrative | 1.37M (+2.24%) | 1.34M (-16.25%) | 1.60M (-8.57%) | 1.75M (+10.76%) | 1.58M (-19.80%) | 1.97M (+20.86%) | 1.63M (-29.13%) | 2.30M (-18.44%) | 2.82M (-11.04%) | 3.17M (+79.10%) | 1.77M (+3.51%) | 1.71M (-9.52%) | 1.89M (-64.14%) | 5.27M (+170.26%) | 1.95M | - | 110K | -8.66M | 3.52M (-11.56%) | 3.98M (+188.41%) | 1.38M (+12.20%) | 1.23M (+89.23%) | 650K (+27.45%) | 510K | - |
Operating Expenses | 1.72M (+6.17%) | 1.62M (-20.20%) | 2.03M (-10.57%) | 2.27M (+4.13%) | 2.18M (-22.14%) | 2.80M (-1.06%) | 2.83M (-31.31%) | 4.12M (-5.94%) | 4.38M (-14.29%) | 5.11M (+64.31%) | 3.11M (-9.86%) | 3.45M (+18.97%) | 2.90M (-11.04%) | 3.26M (-7.91%) | 3.54M (+35.11%) | 2.62M (-1.87%) | 2.67M (+1.52%) | 2.63M (-43.32%) | 4.64M (+14.00%) | 4.07M (+176.87%) | 1.47M (-37.97%) | 2.37M (+80.92%) | 1.31M (+43.96%) | 910K | - |
Operating Income | |||||||||||||||||||||||||
Operating Income | -1.72M (+6.17%) | -1.62M (-20.20%) | -2.03M (-10.57%) | -2.27M (+4.13%) | -2.18M (-69.60%) | -7.17M (+153.36%) | -2.83M (-31.31%) | -4.12M | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
Ebit | -1.72M (+6.17%) | -1.62M (-20.20%) | -2.03M (-10.57%) | -2.27M (+4.13%) | -2.18M (-22.14%) | -2.80M (-1.06%) | -2.83M (-31.31%) | -4.12M (-5.94%) | -4.38M (-14.29%) | -5.11M (+64.31%) | -3.11M (-9.86%) | -3.45M (+18.97%) | -2.90M (-11.04%) | -3.26M (-7.91%) | -3.54M (+35.11%) | -2.62M (-1.87%) | -2.67M (+1.52%) | -2.63M (-43.32%) | -4.64M (+16.00%) | -4.00M (+172.11%) | -1.47M (+34.86%) | -1.09M (-16.79%) | -1.31M (+43.96%) | -910.00K (-28.91%) | -1.28M |
EBITDA | -1.68M (+6.33%) | -1.58M (-20.60%) | -1.99M (-11.56%) | -2.25M (+4.65%) | -2.15M (-22.66%) | -2.78M (-1.42%) | -2.82M (-31.55%) | -4.12M (-5.94%) | -4.38M (-14.29%) | -5.11M (+64.31%) | -3.11M (-9.86%) | -3.45M (+18.97%) | -2.90M (-11.04%) | -3.26M (-7.91%) | -3.54M (+35.11%) | -2.62M (-1.87%) | -2.67M (+1.52%) | -2.63M (-43.32%) | -4.64M (+16.00%) | -4.00M (+172.11%) | -1.47M (+34.86%) | -1.09M (-16.79%) | -1.31M (+43.96%) | -910.00K (-28.91%) | -1.28M |
Other Income / Expenses | |||||||||||||||||||||||||
Interest Income | 40K (0.00%) | 40K (0.00%) | 40K (+100.00%) | 20K (-33.33%) | 30K (+200.00%) | 10K (0.00%) | 10K | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
Net Interest Income | 40K (0.00%) | 40K (0.00%) | 40K (+100.00%) | 20K (-33.33%) | 30K (+200.00%) | 10K (0.00%) | 10K | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
Net Income | |||||||||||||||||||||||||
Net Income From Continuing Operations | -1.68M (+6.33%) | -1.58M (-20.60%) | -1.99M (-11.56%) | -2.25M (+4.65%) | -2.15M (-22.66%) | -2.78M (-1.42%) | -2.82M (-31.55%) | -4.12M (-5.94%) | -4.38M (-14.29%) | -5.11M (+64.31%) | -3.11M (-9.86%) | -3.45M (+18.97%) | -2.90M (-11.04%) | -3.26M (-7.91%) | -3.54M (+35.11%) | -2.62M (-1.87%) | -2.67M (+1.52%) | -2.63M (-43.32%) | -4.64M (+16.00%) | -4.00M (+172.11%) | -1.47M (+34.86%) | -1.09M (-16.79%) | -1.31M (+43.96%) | -910.00K (-28.91%) | -1.28M |
Net Income | -1.68M (+6.33%) | -1.58M (-20.60%) | -1.99M (-11.56%) | -2.25M (+4.65%) | -2.15M (-22.66%) | -2.78M (-1.42%) | -2.82M (-31.55%) | -4.12M (-5.94%) | -4.38M (-14.29%) | -5.11M (+64.31%) | -3.11M (-9.86%) | -3.45M (+18.97%) | -2.90M (-11.04%) | -3.26M (-7.91%) | -3.54M (+35.11%) | -2.62M (-1.87%) | -2.67M (+1.52%) | -2.63M (-43.32%) | -4.64M (+16.00%) | -4.00M (+172.11%) | -1.47M (+34.86%) | -1.09M (-16.79%) | -1.31M (+43.96%) | -910.00K (-28.91%) | -1.28M |